Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Enzyme Inhibition01:30

Enzyme Inhibition

91.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Compounds Essential to Human Function01:25

Compounds Essential to Human Function

10.0K
The human body is composed of cells that are fundamentally made up of several different molecules. These molecules are essential to carry out all physiological processes in the body and are broadly classified into organic and inorganic based on their chemical structures.
Inorganic Compounds Essential to Human Functioning
Inorganic compounds essential to human functioning include water, salts, acids, and bases. These compounds are inorganic, i.e., they do not have a carbon-hydrogen bond. Water...
10.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

643
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
643
T Cell Types and Functions01:24

T Cell Types and Functions

2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosis.

eLifeĀ·2026
Same author

Control of poorly immunogenic tumors with systemic STING agonist-loaded liposomes targeting cross-presenting dendritic cells.

Clinical & translational immunologyĀ·2026
Same author

Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy.

Journal for immunotherapy of cancerĀ·2025
Same author

Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease.

Hepatology communicationsĀ·2025
Same author

Toward a CRISPR-based mouse model of <i>Vhl</i>-deficient clear cell kidney cancer: Initial experience and lessons learned.

Proceedings of the National Academy of Sciences of the United States of AmericaĀ·2024
Same author

Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity.

Cancer immunology researchĀ·2024

Related Experiment Video

Updated: Jan 21, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

15.0K

BET Bromodomain Inhibition Suppresses Human T Cell Function.

Peter Georgiev1, Yun Wang2, Eric S Muise2

  • 1Merck & Co., Inc., Kenilworth, NJ 07033 peter.georgiev@merck.com.

Immunohorizons
|July 30, 2019
PubMed
Summary

Bromodomain and extraterminal domain (BET) protein inhibition with MK-8628 suppresses human T cell activation, proliferation, and cytokine production. This epigenetic perturbation has significant implications for targeting T cell-driven autoimmune inflammation.

More Related Videos

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.6K
Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

12.6K

Related Experiment Videos

Last Updated: Jan 21, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

15.0K
Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.6K
Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

12.6K

Area of Science:

  • Immunology
  • Epigenetics
  • Molecular Biology

Background:

  • Bromodomain and extraterminal domain (BET) proteins regulate T cell differentiation.
  • The role of BET proteins in activated T cell function remains incompletely understood.

Purpose of the Study:

  • To investigate the effects of BET protein inhibition on human T lymphocyte function.
  • To characterize the consequences of epigenetic perturbation using the BET inhibitor MK-8628.

Main Methods:

  • Treatment of human T lymphocytes with MK-8628, a selective BET inhibitor.
  • Analysis of gene expression, cell cycle progression, apoptosis, and cytokine production.
  • Assessment of T cell activation and function in naive and memory T cell subsets.

Main Results:

  • MK-8628 reduced expression of key transcripts for T cell proliferation, activation, and effector function.
  • BET inhibition induced G1 cell cycle arrest by abolishing cyclin expression and increased T lymphocyte apoptosis.
  • MK-8628 antagonized T cell activation and suppressed polyfunctional cytokine production in naive and memory T cells.

Conclusions:

  • BET inhibition exerts potent immunosuppressive effects on human T cell biology.
  • Targeting BET proteins offers a potential strategy for immune modulation in T cell-driven autoimmune diseases.